Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LATS1 | O95835 | 1/20 | 0.50 |
| ▸ | CSNK1E | P49674 | 5/20 | 0.49 |
| ▸ | PIM1 | P11309 | 3/20 | 0.38 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.37 |
| ▸ | PRKD2 | Q9BZL6 | 1/20 | 0.37 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.36 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.36 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.35 |
| ▸ | EIF2AK4 | Q9P2K8 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 2/20 | 0.34 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.34 |
| ▸ | CDK4 | P11802 | 5/20 | 0.33 |
| ▸ | CDK6 | Q00534 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1744649 | 0.82 | CSNK1E (0.58) | LATS1CSNK1EPIM1PRKD1PRKD2 | |
| SCHEMBL1744572 | 0.80 | CSNK1E (0.38) | LATS1CSNK1EPIM1PRKD1PRKD2 | |
| SCHEMBL1744349 | 0.78 | CSNK1E (0.66) | LATS1CSNK1EPIM1PRKD1PRKD2 | |
| SCHEMBL1744357 | 0.78 | CSNK1E (0.55) | LATS1CSNK1EPIM1PRKD1PRKD2 | |
| SCHEMBL3115650 | 0.74 | CSNK1E (0.73) | LATS1CSNK1E | |
| SCHEMBL1744432 | 0.70 | CSNK1E (0.52) | LATS1CSNK1EPIM1PRKD1PRKD2 | |
| SCHEMBL3357961 | 0.68 | PRKD1 (0.69) | LATS1CSNK1EPRKD1PRKD2PRKCQ | |
| SCHEMBL20548063 | 0.67 | LATS1 (1.00) | LATS1CSNK1EPRKD1PRKCQ | |
| SCHEMBL3116817 | 0.66 | CSNK1E (1.00) | LATS1CSNK1E | |
| SCHEMBL1744576 | 0.66 | CSNK1E (0.92) | LATS1CSNK1E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2385946-A1 | DERIVATIVES OF 6-CYCLOAMINO-2,3-DI-PYRIDINYL-IMIDAZO[1,2-B]-PYRIDAZINE, PREPARATION AND TUERAPEUTIC APPLICATION THEREOF | SANOFI (FR) | 2011-11-16 | — | — | EP | disclosed |
| US-8040450-B2 | Liquid crystal electro-optic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-10-18 | — | — | US | disclosed |
| WO-2010070238-A1 | DERIVATIVES OF 6-CYCLOAMINO-2,3-DI-PYRIDINYL-IMIDAZO[1,2-B]-PYRIDAZINE, PREPARATION AND THERAPEUTIC APPLICATION THEREOF | SANOFI-AVENTIS (FR) | 2010-06-24 | — | — | WO | disclosed |
| WO-2010070238-A1 | DERIVATIVES OF 6-CYCLOAMINO-2,3-DI-PYRIDINYL-IMIDAZO[1,2-B]-PYRIDAZINE, PREPARATION AND THERAPEUTIC APPLICATION THEREOF | SANOFI-AVENTIS (FR) | 2010-06-24 | — | — | WO | disclosed |